Kathi Niffenegger
2021
In 2021, Kathi Niffenegger earned a total compensation of $1M as Chief Financial Officer at Edesa Biotech, a 106% increase compared to previous year.
Compensation breakdown
| Bonus | $100,000 |
|---|---|
| Option Awards | $605,875 |
| Salary | $305,016 |
| Other | $30,908 |
| Total | $1,041,781 |
Niffenegger received $605.9K in option awards, accounting for 58% of the total pay in 2021.
Niffenegger also received $100K in bonus, $305K in salary and $30.9K in other compensation.
Rankings
In 2021, Kathi Niffenegger's compensation ranked 8,661st out of 12,405 executives tracked by ExecPay. In other words, Niffenegger earned more than 30.2% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 8,661 out of 12,405 | 30th |
Division Manufacturing | 3,840 out of 5,494 | 30th |
Major group Chemicals And Allied Products | 1,695 out of 2,369 | 29th |
Industry group Drugs | 1,508 out of 2,090 | 28th |
Industry Pharmaceutical Preparations | 1,123 out of 1,537 | 27th |
Source: SEC filing on April 1, 2022.
Niffenegger's colleagues
We found two more compensation records of executives who worked with Kathi Niffenegger at Edesa Biotech in 2021.
News
Edesa Biotech CEO Pardeep Nijhawan's 2023 pay slips 9% to $550K
April 5, 2024
Edesa Biotech CEO Pardeep Nijhawan's 2022 pay falls 54% to $602K
March 28, 2023
Edesa Biotech CEO Pardeep Nijhawan's 2021 pay jumps 221% to $1.3M
April 1, 2022
Edesa Biotech President Michael Brooks' 2020 pay jumps 155% to $529K
March 3, 2021
Edesa Biotech President Michael Brooks' 2019 pay slips 10% to $207K
March 23, 2020